Renalytix (LSE:RENX) Days Payable : 632.10 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Renalytix Days Payable?

Renalytix's average Accounts Payable for the three months ended in Dec. 2023 was £2.47 Mil. Renalytix's Cost of Goods Sold for the three months ended in Dec. 2023 was £0.36 Mil. Hence, Renalytix's Days Payable for the three months ended in Dec. 2023 was 632.10.

The historical rank and industry rank for Renalytix's Days Payable or its related term are showing as below:

LSE:RENX' s Days Payable Range Over the Past 10 Years
Min: 349.02 Med: 371.18 Max: 966.01
Current: 542.02

During the past 6 years, Renalytix's highest Days Payable was 966.01. The lowest was 349.02. And the median was 371.18.

LSE:RENX's Days Payable is ranked better than
93.91% of 591 companies
in the Healthcare Providers & Services industry
Industry Median: 61.52 vs LSE:RENX: 542.02

Renalytix's Days Payable increased from Dec. 2022 (560.08) to Dec. 2023 (632.10). It may suggest that Renalytix delayed paying its suppliers.

Renalytix Days Payable Historical Data

The historical data trend for Renalytix's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renalytix Days Payable Chart

Renalytix Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Days Payable

Get a 7-Day Free Trial

966.01

349.02

371.18

Renalytix Quarterly Data
	Dec18	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Payable	Get a 7-Day Free Trial															560.08	554.66	424.66	567.05	632.10

Competitive Comparison of Renalytix's Days Payable

For the Health Information Services subindustry, Renalytix's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Renalytix's Days Payable Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Renalytix's Days Payable distribution charts can be found below:

* The bar in red indicates where Renalytix's Days Payable falls into.

Renalytix Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Renalytix's Days Payable for the fiscal year that ended in Jun. 2023 is calculated as

	Days Payable (A: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Jun. 2022 )	+	Accounts Payable (A: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (A: Jun. 2023 )	*	Days in Period
=	( (1.997	+	2.325)	/	2 )	/	2.125	*	365
=	2.161					/	2.125	*	365
=	371.18

Renalytix's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (2.721	+	2.225)	/	2 )	/	0.357	*	365 / 4
=	2.473					/	0.357	*	365 / 4
=	632.10

Renalytix Days Payable Related Terms

Thank you for viewing the detailed overview of Renalytix's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Renalytix (LSE:RENX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Renalytix PLC (LSE:RENX) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

RNLX:USA RTNXF:USA 2O9:Germany

Address

5-7 Cranwood Street, Finsgate, London, GBR, EC1V 9EE

Website

https://www.renalytix.com

Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Renalytix (LSE:RENX) Headlines

From GuruFocus

Paul Singer Buys Reed Elesvier

By matsandalex matsandalex • 12-14-2012

Investing in Information

By Vanina Egea Vanina Egea • 03-06-2014

Omnicom Health Group acquires Elsevier's Pharma Communications business in Japan, rebrands as EMC K.K.

By PRNewswire PRNewswire • 03-27-2018

Causeway International's Top Five Holdings

By Monica Wolfe Monica Wolfe • 08-29-2013